FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

787753009: Product containing halobetasol and tazarotene in cutaneous dose form (medicinal product form)


Status: current, Defined. Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3776804014 Product containing halobetasol and tazarotene in cutaneous dose form (medicinal product form) en Fully specified name Active Case insensitive SNOMED CT core
3779171015 Halobetasol- and tazarotene-containing product in cutaneous dose form en Synonym Active Case insensitive SNOMED CT core


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Halobetasol- and tazarotene-containing product in cutaneous dose form Is a Halobetasol- and tazarotene-containing product true Inferred relationship Some
Halobetasol- and tazarotene-containing product in cutaneous dose form Is a Tazarotene-containing product in cutaneous dose form true Inferred relationship Some
Halobetasol- and tazarotene-containing product in cutaneous dose form Has manufactured dose form Cutaneous dose form true Inferred relationship Some
Halobetasol- and tazarotene-containing product in cutaneous dose form Is a Halobetasol-containing product in cutaneous dose form true Inferred relationship Some
Halobetasol- and tazarotene-containing product in cutaneous dose form Has active ingredient Tazarotene true Inferred relationship Some 1
Halobetasol- and tazarotene-containing product in cutaneous dose form Has active ingredient Halobetasol true Inferred relationship Some 2

Inbound Relationships Type Active Source Characteristic Refinability Group
Halobetasol and tazarotene only product in cutaneous dose form Is a True Halobetasol- and tazarotene-containing product in cutaneous dose form Inferred relationship Some

Reference Sets

Australian dialect reference set

Back to Start